Rapamycin-resistant polyclonal Th1/Tc1 cell therapy (RAPA-201) safely induces disease remissions in relapsed, refractory multiple myeloma
Background Polyclonal autologous T cells that are epigenetically reprogrammed through mTOR inhibition and IFN-α polarization (RAPA-201) represent a novel approach to the adoptive T cell therapy of cancer. Ex vivo inhibition of mTOR results causes a shift towards T central memory (TCM) whereas ex viv...
Saved in:
Main Authors: | Lawrence G Lum, Parameswaran Hari, Aniko Szabo, Michele Donato, Jee Hyun Park, Daniel H Fowler, Binod Dhakal, Saurabh Chhabra, Deborah D Glass, David S Siegel, Tania C Felizardo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/13/1/e010649.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pieris Rapae in Mid-ocean
by: Samuel H. Scudder
Published: (1876-01-01) -
Comparative transcriptomic and phenotypic analysis of monoclonal and polyclonal Populus deltoides genotypes
by: Macy Gosselaar, et al.
Published: (2025-01-01) -
Late remission in diabetes mellitus type 1. Presentation of a case.
by: Hiussymin Marchena Morera, et al.
Published: (2007-12-01) -
Evaluation of Brain SPECT with 99mTc-TRODAT-1 in the Differential Diagnosis of Parkinsonism
by: Giorgio Fabiani, et al.
Published: (2022-01-01) -
Chloroquine and Rapamycin Augment Interleukin-37 Expression via the LC3, ERK, and AP-1 Axis in the Presence of Lipopolysaccharides
by: Xiaoyi Shi, et al.
Published: (2020-01-01)